organovo holdings inc
(ONVO:Consolidated issues listed on NYSE MKT LLC)
James T. Glover
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee, Organovo Holdings, Inc.
|Age||Total Calculated Compensation||This person is connected to 10 board members in 1 different organizations across 3 different industries.|
See Board Relationships
Mr. James T. Glover served as the Chief Financial Officer and Senior Vice President of Operations at Anadys Pharmaceuticals Inc. from September 25, 2006 to September 2009 and served as its Principal Accounting Officer until September 2009. Mr. Glover served as Chief Financial Officer and Senior Vice President of Beckman Coulter Inc. from March 19, 2004 and July 12, 2005 respectively to June 30, 2006. He held several Financial Management positions at Beckman Coulter Inc. ...
6275 Nancy Ridge DrivePhone: 858-550-9994
San Diego, California 92121
Board Members Memberships*
Independent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
California State Polytechnic University, Pomona
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Michael D. West Ph.D.||Chief Executive Officer, President and Director|
|Marc H. Hedrick M.D.||Chief Executive Officer, President, Director and Member of Executive Committee|
Cytori Therapeutics, Inc.
|David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.||Chief Executive Officer and Director|
|David M. Pernock||Chairman of the Board, Chief Executive Officer and President|
Fibrocell Science, Inc.
|Paul K. Wotton Ph.D.||Chief Executive Officer, President, Director and Member of Pricing Committee|
Ocata Therapeutics, Inc.
|$314.4K||Compensation as of Fiscal Year 2013.|